Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C: Results of a multicenter randomized trial
- 31 July 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 27 (1), 56-62
- https://doi.org/10.1016/s0168-8278(97)80280-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-α2b for 60 weeksHepatology, 1994
- Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trialHepatology, 1994
- Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2bHepatology, 1993
- Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitisGastroenterology, 1991
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from FranceHepatology, 1991
- Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experienceJournal of Hepatology, 1990
- A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitisJournal of Hepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989